Skip to content

Ethanol Assay for the Bayer Advia Integrated Module System

by Bayer Diagnostics Corp. 510(k)

Active United States

510(k) K023184

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK023184 Date18 Nov 2002ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 6 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DIC
Device Class
Class II
Regulation
21 CFR Part 862.3040
Advisory Committee
Clinical Toxicology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 25 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is an in vitro diagnostic reagent intended for the quantitative measurement of ethanol concentration in human serum or plasma (lithium heparin). It is classified as Alcohol Dehydrogenase, Specific Reagent For Ethanol Enzyme Method under regulation 862.3040 and falls within the medical specialty of Clinical Toxicology.

The assay is supplied for use with the Bayer Advia Integrated Module System and is indicated for diagnosing ethanol toxicity and overdose. It received FDA 510(k) clearance (K023184) on November 18, 2002, following a traditional review process, and is classified as a Class II medical device.

Other devices from Bayer Diagnostics Corp.

See all devices from Bayer Diagnostics Corp. →

Questions

AI-generated answers, 25 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the ethanol assay for the Bayer Advia Integrated Module System used for?

    This assay is an in vitro diagnostic reagent intended for the quantitative measurement of ethanol concentration in human serum or plasma (lithium heparin). It is used to diagnose ethanol toxicity and overdose by measuring alcohol levels via an enzyme-based method specific to ethanol.

  • How is the ethanol assay supplied and what system is it designed for?

    The assay is supplied as a reagent for use exclusively with the Bayer Advia Integrated Module System. It is formatted to integrate with this automated platform for clinical laboratory testing of ethanol in serum or plasma samples.

  • Is the ethanol assay for the Bayer Advia system a single-use or reusable reagent?

    The reagent is intended for single-use in diagnostic testing. Each test consumes the reagent components, and it is not designed for reuse after initial application, consistent with standard in vitro diagnostic reagents for enzymatic assays.

  • What regulatory pathway was used for the ethanol assay on the Bayer Advia system?

    The assay received FDA 510(k) clearance under submission K023184 on November 18, 2002, following a traditional review process. It was found substantially equivalent to a legally marketed predicate device and is classified as a Class II medical device.